Johnson & Johnson also owned two companies that processed and imported the raw material used to manufacture oxycodone, a highly addictive opioid. ADIn August, a judge in Oklahoma ordered Johnson & Johnson to pay $572 million for allegedly helping to fuel Oklahoma’s opioid epidemic. Johnson & Johnson has denied any wrongdoing and has appealed. ADThe Johnson & Johnson settlement comes a little more than three weeks after Ireland-based Mallinckrodt Pharmaceuticals, one of the largest manufacturers of generic opioids in the United States, announced it had reached a “settlement in principle” with the two Ohio counties. The pending deals, aside from the proposed Purdue Pharma settlement, would address only the cases in the two Ohio counties.

Source: Washington Post October 02, 2019 00:07 UTC